Home Tags OBI-999

Tag: OBI-999

U.S. FDA Grants Orphan Drug Designation for OBI-999 in Gastric Cancer

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to OBI Pharma's OBI-999 for the treatment of Gastric Cancer.Gastric or stomach...

OBI-999, a Novel First-in-class ADC, Granted FDA Orphan Drug Designation for...

OBI-999, a novel antibody-drug conjugate or ADC being developed by OBI Pharma, a Taiwan based biopharmaceutical company, has been granted orphan drug designation for...